Edoxaban Impurity 151 | CAS 1392745-59-3 - Request Quote
Edoxaban Impurity 151
| SZ CAT No: | SZ-E041188 |
| CAS No | 1392745-59-3 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 151 is chemically Ethyl (1S,3R,4R)-4-amino-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate. Edoxaban Impurity 151 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 151 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1392745-59-3
Purchase 1392745-59-3
Order 1392745-59-3
Enquire 1392745-59-3
price of 1392745-59-3
1392745-59-3 Supplier
1392745-59-3 Manufacturer
1392745-59-3 Exporter
buy high quality Edoxaban Impurity 151
Purchase Edoxaban Impurity 151
Edoxaban Impurity 151 suppliers
Edoxaban Impurity 151 manufacturers
Edoxaban Impurity 151 price
Order Edoxaban Impurity 151
Enquire Edoxaban Impurity 151
Edoxaban Impurity 151 cost
Edoxaban Impurity 151 Supplier
Edoxaban Impurity 151 Distributor
Edoxaban Impurity 151 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 151 for ANDA Filing
Edoxaban Impurity 151 for Forced Degradation Studies
Edoxaban Impurity 151 Identification Standards
Edoxaban Impurity 151 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.